The Usefulness of the Pretreatment Neutrophil/Lymphocyte Ratio as a Predictor of the 5-Year Survival in Stage 1-3 Triple Negative Breast Cancer Patients

Basem Azab, Julia R. Amundson, Alessia Cioci, Heather Stuart, Danny Yakoub, Eli Avisar, Fredrick Moffat, Alan S. Livingstone, Dido Franceschi

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'The Usefulness of the Pretreatment Neutrophil/Lymphocyte Ratio as a Predictor of the 5-Year Survival in Stage 1-3 Triple Negative Breast Cancer Patients'. Together they form a unique fingerprint.

Medicine & Life Sciences